Although generally not curative with the exception of ALK+ ALCL, cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) is the most commonly prescribed initial treatment for systemic PTCL. This evidence concerns the gene ALK and mature T-cell and NK-cell non-Hodgkin lymphoma.